CSP402 - VA Topical tretinoin chemoprevention trial

Trial Profile

CSP402 - VA Topical tretinoin chemoprevention trial

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2013

At a glance

  • Drugs Tretinoin (Primary)
  • Indications Basal cell cancer; Squamous cell cancer
  • Focus Adverse reactions; Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms VATTC
  • Most Recent Events

    • 01 Oct 2009 Published in British Journal of Dermatology.
    • 29 Jan 2009 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top